MINNEAPOLIS, June 18, 2009 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is set to join the broad-market Russell 3000(r) Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 26, 2009, according to a preliminary list of additions posted June 12, 2009 on www.russell.com.
Annual reconstitution of Russell's U.S. indexes consists of the largest U.S. stocks at the end of May, ranking them by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the small-market Russell 2000(r) Index as well as the appropriate growth and value style indexes.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Approximately $4 trillion in assets are currently benchmarked to the Russell indexes. Total returns data for the Russell 3000 and other Russell indexes is available at www.russell.com/indexes/performance/default.asp.
"We are pleased to be on the preliminary list for addition to the Russell 3000 Index. The Russell indexes are broadly recognized as key tools for investors to track market performance and trends. We believe that inclusion in the Russell 3000 will result in increased visibility for Vascular Solutions within the investment community as well as significant stock ownership by the index funds," commented Howard Root, Chief Executive Officer.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company's product line consists of five major categories: hemostat (blood clotting) products, extraction (clot removal) catheters, vein products, specialty catheters and access products. Vascular Solutions delivers its proprietary and distributed products to interventional cardiologists, interventional radiologists and vascular surgeons through its direct U.S. sales force and international distributor network.
About Russell
Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has $136 billion in assets under management as of March 31, 2009, and serves individual, institutional and advisor clients in more than 40 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company. Russell 2000 and Russell 3000 are registered trademarks of Russell Investments.
Vascular Solutions has no ability to control and gives no assurances as to whether inclusion in the Russell 3000 or other Russell indexes will have any effect on the volume, liquidity, price or other trading characteristics of the Company's common stock, or whether Vascular Solutions will continue to be included within the Russell indexes for any period of time. The standards for inclusion in any of the Russell indexes are determined by Russell Investments, are outside of the Company's control, and are subject to change.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2008 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, limited working capital, lack of sustained profitability, exposure to intellectual property claims, exposure to possible product liability claims, the development of new products by others, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to www.vascularsolutions.com.